KRAS and lung cancer: To determine whether the Rpa-RX3-AC complex formation is also sensitive enough to respond to the heterozygous oncogenic K-Ras mutation, we obtained immortalized cell lines from KPRL/F-TAM(-) lung cancers (KPR-) (Figure 5F).